EVANGELINE FRIEDBAUM: Open Payments
NPI 1073225348 · FOREST GROVE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: CAPLYTA, TRELEGY ELLIPTA, BREZTRI, SLYND, TRINTELLIX, FANAPT, Veozah.
Industry payments across OR — which companies pay providers there.
